How low can you go?

Extremely low numbers of active epidermal growth factor receptors are sufficient to drive tumor growth.

[1]  R. Kumar,et al.  Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. , 1991, The Journal of biological chemistry.

[2]  G. MacBeath,et al.  High- and Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways , 2011, PloS one.

[3]  Simon C Watkins,et al.  EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo , 2017, eLife.

[4]  Matthew S. Creamer,et al.  Use of mechanistic models to integrate and analyze multiple proteomic datasets. , 2015, Biophysical journal.

[5]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[6]  Jianchun Chen,et al.  Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease. , 2016, Physiological reviews.

[7]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[8]  Peter K. Sorger,et al.  Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway , 2016, Science Signaling.

[9]  R. Harris,et al.  Epidermal growth factor, from gene organization to bedside. , 2014, Seminars in cell & developmental biology.

[10]  D A Lauffenburger,et al.  Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture. , 2001, Journal of cell science.

[11]  S. Chow,et al.  Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay. , 1997, Gynecologic oncology.